Singapore Busts Illicit Vape Production; Suspect Charged with Five Offenses

Jul.18.2025
Singapore Busts Illicit Vape Production; Suspect Charged with Five Offenses
A 41-year-old man in Singapore has been charged with multiple offenses, including violations of the Tobacco (Control of Advertisements and Sale) Act and the Poisons Act, for allegedly manufacturing e-cigarettes containing the controlled substance etizolam at his residence.

Key points:

 

·A 41-year-old man in Singapore is facing charges for allegedly manufacturing e-cigarettes containing drugs. 

 

·He is accused of violating the Tobacco (Control of Advertisements and Sale) Act. Over a thousand e-cigarette components and a large quantity of empty pods were seized from him. 

 

·The man has expressed his intention to plead guilty and is scheduled to appear in court on July 23rd.

 


【2Firsts News Flash】According to a report by Malaymail on July 17, a 41-year-old man in Singapore is being accused of illegally manufacturing e-cigarettes containing drugs in his home. The defendant, Mohammed Akil Abdul Rahim, is facing five charges under the Tobacco (Control of Advertisements and Sale) Act for allegedly manufacturing e-cigarettes in a block of flats in Yishun.

 

The accusation documents show that on December 11, 2024, law enforcement officers found 569 empty pod casings, 534 components, 1,485 pod covers, and 100 electronic pods at his residence. These tools and materials are believed to be used in the manufacturing of Kpodspods laced with fentanyl, which has garnered increasing public concern.

 

The prosecutor from the Health Sciences Authority (HSA) in Singapore told the court that they have prepared a plea agreement for the case. The defendant appeared in court via video link and expressed willingness to plead guilty to all charges, and stated that he does not plan to hire a lawyer.

 

The man was previously charged under the Poisons Act for possession and sale of the controlled hospital-grade sedative, etomidate. It is alleged that he sold 100 electronic pods containing the substance at the same location just past midnight on December 11. He was found in possession of 26.4 grams of white powder testing positive for the substance at around 5:30am that same morning.

 

Propofol is commonly used for intravenous sedation in medical procedures, but if inhaled or ingested, it can lead to serious side effects including seizures, difficulty breathing, and confusion.

 

In addition, the defendant also faces charges under the Passport Act for falsely claiming to the Immigration and Checkpoints Authority in January 2025 that he had lost his passport at a coffee shop. He has been in custody since June 20 and is expected to plead guilty on July 23.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Frank Vandenbroucke described the tobacco industry as a “criminal” sector with “no future” during an appearance on VRT’s current affairs program Ter Zake. His comments came after Belgium’s Constitutional Court ruled that a government ban on cigarette and vape sales in supermarkets was discriminatory because it allowed small shops to sell tobacco products while prohibiting larger retailers from doing so.
May.07 by 2FIRSTS.ai
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia will strengthen surveillance of vapes amid growing concerns over drug-laced e-cigarettes. The National Food and Drug Monitoring Agency, or BPOM, will soon take charge of monitoring nationwide vape distribution and said it will work with the National Narcotics Agency, or BNN. BNN recently floated a plan to completely ban e-cigarettes, saying a total ban was the only way to prevent liquid narcotics.
May.11 by 2FIRSTS.ai